ACLX
Price
$72.62
Change
+$0.46 (+0.64%)
Updated
Sep 5 closing price
Capitalization
4.03B
71 days until earnings call
REGN
Price
$573.38
Change
+$6.16 (+1.09%)
Updated
Sep 5 closing price
Capitalization
60.77B
53 days until earnings call
Interact to see
Advertisement

ACLX vs REGN

Header iconACLX vs REGN Comparison
Open Charts ACLX vs REGNBanner chart's image
Arcellx
Price$72.62
Change+$0.46 (+0.64%)
Volume$364.16K
Capitalization4.03B
Regeneron Pharmaceuticals
Price$573.38
Change+$6.16 (+1.09%)
Volume$960.39K
Capitalization60.77B
ACLX vs REGN Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. REGN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and REGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ACLX: $72.62 vs. REGN: $573.38)
Brand notoriety: ACLX: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 75% vs. REGN: 100%
Market capitalization -- ACLX: $4.03B vs. REGN: $60.77B
ACLX [@Biotechnology] is valued at $4.03B. REGN’s [@Biotechnology] market capitalization is $60.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 7 TA indicator(s) are bullish while REGN’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 7 bullish, 2 bearish.
  • REGN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than REGN.

Price Growth

ACLX (@Biotechnology) experienced а +4.65% price change this week, while REGN (@Biotechnology) price change was -1.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

REGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($60.8B) has a higher market cap than ACLX($4.03B). ACLX YTD gains are higher at: -5.307 vs. REGN (-19.161). ACLX has less debt than REGN: ACLX (52.5M) vs REGN (2.71B).
ACLXREGNACLX / REGN
Capitalization4.03B60.8B7%
EBITDA-179.78MN/A-
Gain YTD-5.307-19.16128%
P/E RatioN/A14.45-
Revenue57MN/A-
Total Cash453MN/A-
Total Debt52.5M2.71B2%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXREGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
51%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 14 days ago
78%
Bearish Trend 5 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
41%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVES56.160.72
+1.30%
Avantis Emerging Markets Value ETF
ROAM27.070.22
+0.80%
Hartford Multifactor Emerging Mkts ETF
VPV10.100.07
+0.65%
Invesco Pennsylvania Value Municipal Income Trust
SHY82.920.12
+0.14%
iShares 1-3 Year Treasury Bond ETF
GUMI50.260.02
+0.04%
Goldman Sachs Ultra Shrt Muncpl Inc ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with RNA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.64%
RNA - ACLX
55%
Loosely correlated
+3.90%
CGON - ACLX
55%
Loosely correlated
+6.88%
ROIV - ACLX
54%
Loosely correlated
+2.78%
XNCR - ACLX
52%
Loosely correlated
+2.15%
CRNX - ACLX
52%
Loosely correlated
+3.97%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with ROIV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
+1.09%
ROIV - REGN
40%
Loosely correlated
+2.78%
IDYA - REGN
39%
Loosely correlated
+5.15%
TECH - REGN
39%
Loosely correlated
+2.82%
APGE - REGN
38%
Loosely correlated
+1.99%
INCY - REGN
38%
Loosely correlated
+1.40%
More